Description

LL37 ™

LL37 ™ peptide is one of the body’s most powerful natural defenses, acting as a human antimicrobial peptide with wide‑ranging roles in immunity, healing, and infection control. Produced by immune cells and epithelial tissues, LL‑37 helps protect against bacteria, viruses, and fungi, while also guiding the body’s inflammatory and repair processes.

Unlike synthetic antibiotics, LL‑37 is part of the body’s innate immune system, working as both a direct antimicrobial agent and an immune modulator. It can disrupt bacterial biofilms, neutralize toxins, and accelerate wound healing — making it a subject of intense research in fields ranging from infectious disease to cancer therapy.

Although LL‑37 shows promise in clinical applications, it is not yet an FDA‑approved drug. Researchers continue to explore its potential as a next‑generation therapeutic peptide, balancing its powerful protective effects with the risks of excessive inflammation.

What Is LL‑37

• Full name: Human cathelicidin antimicrobial peptide LL‑37
• Structure: Amphipathic alpha‑helix, 37 amino acids long
• Gene: CAMP (cathelicidin antimicrobial peptide)
• Precursor protein: hCAP18 (human cationic antimicrobial protein 18)
• Charge: Net +6 at physiological pH
• Primary producers: Neutrophils, macrophages, epithelial cells (skin, lung, gut)

Key Functions

• Antimicrobial defense: Kills bacteria, fungi, and viruses by disrupting membranes.
• Immune modulation: Recruits immune cells to infection sites and directs inflammatory signaling.
• Wound healing: Promotes tissue repair and angiogenesis.
• Biofilm disruption: Breaks down bacterial biofilms that resist antibiotics.
• Toxin neutralization: Neutralizes bacterial endotoxins.

Risks & Precautions

• Excess LL‑37 can drive inflammation, contributing to conditions like psoriasis and rosacea.
• Abnormal processing may worsen autoimmune or chronic inflammatory diseases.
• Not FDA‑approved: LL‑37 is listed under FDA’s 503A bulks list, meaning it is not an approved therapeutic.

LL37 ™ Research Applications

• Infections: Potential use in treating antibiotic‑resistant bacteria.
• Cancer: Studied for its role in tumor immunity.
• Dermatology: Investigated in wound healing, psoriasis, and rosacea.
• Respiratory health: Explored for lung infections and asthma modulation.

📊 Comparison Table

🏁 Conclusion

The LL‑37™ peptide is a master antimicrobial molecule with wide‑ranging roles in human immunity, wound healing, and infection control. While promising in research, it is not yet an approved therapeutic and requires careful regulation due to its potential to trigger inflammation.